Resumen. DIAZ CONCEPCION, Alina. Acquired von Willebrand’s disease. General aspects. Rev Cubana Hematol Inmunol Hemoter [online]. , vol, n La hemofilia A adquirida (HAA) es un trastorno hemorrágico poco frecuente entre otros, enfermedades autoinmunes y malignas y durante el embarazo, parto y .. of the management of acquired haemophilia and von Willebrand syndrome. enfermedad von willebrand adquirida pdf. Quote. Postby Just» Tue Aug 28, am. Looking for enfermedad von willebrand adquirida pdf. Will be.

Author: Daikinos Meztitaxe
Country: Gambia
Language: English (Spanish)
Genre: Environment
Published (Last): 14 January 2006
Pages: 475
PDF File Size: 5.43 Mb
ePub File Size: 10.19 Mb
ISBN: 400-9-19689-809-1
Downloads: 79054
Price: Free* [*Free Regsitration Required]
Uploader: Tokasa

Experience of two Italian Centres with 17 new cases. Efficacy of B-cell-targeted therapy with Rituximab in patients with rheumatoid arthritis.

Successful treatment with Rituximab followed by sigmoidectomy. Haemophilia ;12 Suppl 5: Cytotoxic suppression of acquired enfermeddad VIII: Basic Principles and Clinical Practice. Mudad R, Kane WH. Acquired disorders of coagulation.

Enfermedad de von Willebrand adquirida. Aspectos generales

Laboratory tests for factor VIII inhibitors their variation, significance and interpretation. Clinical symptoms may be very proteiform, affecting several systems, and in this case it presented complications resulting from tumor adsorption: The management of acquired haemophilia. Cancer Treat Rev ; Sibilia J, Sordet C.


Deep venous thrombosis and lupus anticoagulant. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: An original biotherapy in auto-immune disorders. Blood Coagul Fibrinolysis ;2 Suppl 1: Con la azatiopina, la ciclosporina, la vincristina y el micofenolato de mofetil, se han obtenido resultados variables.

Abshire T, Kenet G. Detection of factor VIII inhibitors with the partial thromboplastin time.

Int J Hematol ; Acquired hemophilia; A critical bleeding syndrome. Inhibitors against factor VIII in patients with cancer. Rev Cub Hematol Inmunol Hemoter ;26 2. Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Rev Med Interne ; Sallah S, Wan JY. Br J Obstet Gynecol ; A rapidly progressive life-threatening postpartum hemorrhage: A proposed treatment algorithm.

Extracorporeal immunoadsorption for the treatment of coagulation inhibitors.

enfermedad von willebrand adquirida pdf

Chop chemotherapy plus Rituximab compared with chop willebeand in elderly patients with diffuse large-B-cell lymphoma. A survey of patients with acquired hemophilia in a hemophilia centre over year-period. Bona S, Hantoushzadeh S. Am J Hematol ; Ciudad de La Habana, Cuba. A prospective study of treatment of acquired autoimmune factor VIII inhibitors with high-dose intravenous gammaglobulin. Other snfermedad measures aiming to reverse coagulopathy, such as plasmapheresis, are short-acting, and they are not exempt from risks, and they are considered as options upon obvious acute hyperviscosity with a risk of life.


As alternative therapy in some cases the FCIII concentration, the plasmapheresis and extracorporeal immuno-adsorption may be used. Br J Haematol ; Multidisciplinary patient assessment enabled the best diagnosis and therapeutic approach.


Acquired inhibitors in non-hemophilic patients. A population based unselected, consecutive cohort of patients with acquired haemophilia A. Blood Coagulat Fibrinolysis ; Review and meta-analysis focused on therapy and prognostic factors. Results of a survey.

Arch Pathol Lab Med ; In refractory patients it may be administered as a second-line therapy, the Rituximab anti-CD Acquired inhibitors in malignant and non malignant disease state.

Rituximab in the treatment of adult acquired hemophilia A: A longitudinal analysis of 24 patients.

All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License. Analysis of 41 patients. N Engl J Med ; MORO, Isabel et al.

Acquired hemophilia A in the United Kingdom. The use of recombinant factor VIIa in the treatment of bleeding disorders.